During the past decade, Asklepios Klinik Hamburg Altona, II. Med. Klinik conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Asklepios Klinik Hamburg Altona, II. Med. Klinik" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Asklepios Klinik Hamburg Altona, II. Med. Klinik" in a lesser frequency.

Most popular intervention types in "Asklepios Klinik Hamburg Altona, II. Med. Klinik" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (2 trials), "Dexamethasone" (2 trials), "Lenalidomide" (2 trials), "Isatuximab" (1 trials) and "elotuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios Klinik Hamburg Altona, II. Med. Klinik" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Asklepios Klinik Hamburg Altona, II. Med. Klinik". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Asklepios Klinik Hamburg Altona, II. Med. Klinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios Klinik Hamburg Altona, II. Med. Klinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".